What is it used for?
JASCAYD is indicated for the treatment of idiopathic pulmonary fibrosis (IPF) in adult patients. JASCAYD is indicated for the treatment of progressive pulmonary fibrosis (PPF) in adult patients.JASCAYD is indicated for the treatment of idiopathic pulmonary fibrosis (IPF) in adult patients. JASCAYD is indicated for the treatment of progressive pulmonary fibrosis (PPF) in adult patients.
Read the primary sourceThis source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.
Product details
- Active ingredient
- nerandomilastnerandomilast
- Form and strength
- TABLET, FILM COATED · 9 mg; TABLET, FILM COATED · 18 mgTABLET, FILM COATED · 9 mg; TABLET, FILM COATED · 18 mg
- Manufacturer / applicant
- BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.
Tablets: 9 mg, light yellow, oval, biconvex, film-coated tablets debossed with the Boehringer Ingelheim company symbol on one side and "F9" on the other side. 18 mg, light red, oval, biconvex, film-coated tablets debossed with the Boehringer Ingelheim …Tablets: 9 mg, light yellow, oval, biconvex, film-coated tablets debossed with the Boehringer Ingelheim company symbol on one side and "F9" on the other side. 18 mg, light red, oval, biconvex, film-coated tablets debossed with the Boehringer Ingelheim …
Safety and clinical review
Ask your clinician to review the complete label, medical history, other medicines, allergies, pregnancy or breastfeeding and any required monitoring. Do not start, stop or change treatment from this page.
Read the primary sourcePrepare your enquiry
Include the brand or generic name, strength, dosage form, requested quantity and country where care is needed. You can attach a prescription when you continue.
Questions patients ask
What is JASCAYD used for?
JASCAYD is indicated for the treatment of idiopathic pulmonary fibrosis (IPF) in adult patients. JASCAYD is indicated for the treatment of progressive pulmonary fibrosis (PPF) in adult patients.JASCAYD is indicated for the treatment of idiopathic pulmonary fibrosis (IPF) in adult patients. JASCAYD is indicated for the treatment of progressive pulmonary fibrosis (PPF) in adult patients.
This source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.
Which formulation of JASCAYD should I ask about?
TABLET, FILM COATED · 9 mg; TABLET, FILM COATED · 18 mgTABLET, FILM COATED · 9 mg; TABLET, FILM COATED · 18 mg
Read the primary sourceWhat determines the price of JASCAYD?
A current quote depends on the exact presentation, quantity, provider and access arrangements. A catalogue entry is not a stock or delivery promise. Medical charges are paid to the provider, separately from coordination fees.
What should I check before using JASCAYD?
Ask your clinician to review the complete label, medical history, other medicines, allergies, pregnancy or breastfeeding and any required monitoring. Do not start, stop or change treatment from this page.
Sources and review scope
This source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.